NCT04530045View on ClinicalTrials.gov

Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients

CompletedOBSERVATIONAL

Enrollment

Participants

Timeline

Start Date

May 2, 2018

Primary Completion Date

November 1, 2019

Study Completion Date

November 2, 2019

Conditions

Critical IllnessAntibiotic ToxicitySepsisSeptic Shock

Interventions

OTHER

dosage of concentration of piperacillin and cefepim

Dosage of total plasma concentration of piperacillin and cefepim at different timepoints

Trial Locations (2)

54500

Emmanuel NOVY, Vandœuvre-lès-Nancy

Central Hospital, Vandœuvre-lès-Nancy

All Listed Sponsors

lead

Central Hospital, Nancy, France

OTHER

NCT04530045 - Target Attainment of TDM-guided Infusion of Piperacillin/Tazobactam and Cefepim in Critically Ill Patients | Biotech Hunter | Biotech Hunter